Karamujić-Čomić, H., Rozemuller, A. J. M., Ikram, M. A., & van Duijn, C. M. (2021). First participant diagnosed with Creutzfeldt-Jakob disease in the population-based Rotterdam Study was classified with mild cognitive impairment. BMJ Case Rep.
Dyfyniad Arddull ChicagoKaramujić-Čomić, Hata, Annemieke J M. Rozemuller, M Arfan Ikram, and Cornelia M. van Duijn. "First Participant Diagnosed With Creutzfeldt-Jakob Disease in the Population-based Rotterdam Study Was Classified With Mild Cognitive Impairment." BMJ Case Rep 2021.
Dyfyniad MLAKaramujić-Čomić, Hata, Annemieke J M. Rozemuller, M Arfan Ikram, and Cornelia M. van Duijn. "First Participant Diagnosed With Creutzfeldt-Jakob Disease in the Population-based Rotterdam Study Was Classified With Mild Cognitive Impairment." BMJ Case Rep 2021.